About Otesaly
Othesaly
represents AOMA’s advanced portfolio of injectable aesthetic solutions,
distinguished by innovation, safety, and performance. Built upon scientific
expertise and clinical reliability, Othesaly products are engineered for
medical professionals who demand results-driven formulations that combine
immediate correction with sustained skin rejuvenation. Each product under the
Othesaly line reflects a commitment to long-term dermal health,
biocompatibility, and elegant, natural-looking outcomes—making it a trusted
name in modern aesthetic medicine.
PllaHAfill®
PllaHAfill®
is a hybrid injectable filler combining cross-linked hyaluronic acid (HA) and
PLLA microspheres (PLLA‑b‑PEG) in a single 1 ml syringe. It provides both
immediate volumizing and hydration from HA and long-term collagen stimulation
from PLLA. The product is CE-certified and designed for mid-to-deep dermal
injections in facial contouring areas such as the temples, cheeks, nose, chin,
and jawline.
About AOMA
AOMA Co., Ltd. (Guangzhou, China) is a leading aesthetic biotech manufacturer established in 2003. Their 4,800 m², GMP-compliant facility holds CE, ISO 13485, FDA, and EDQM certifications. AOMA products are registered across 50+ countries, with a high (96%+) repurchase rate among over 4 million users.